News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kythera Biopharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option


10/16/2012 10:24:51 AM

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced the closing of its initial public offering of 5,060,000 shares of its common stock at an initial public offering price of $16.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 660,000 additional shares of common stock. KYTHERA Biopharmaceuticals’ common stock is listed on the NASDAQ Global Select Market under the trading symbol "KYTH." All of the shares in the offering were offered by KYTHERA Biopharmaceuticals.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES